Altamura S, Muckenthaler MU. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. J Alzheimers Dis. 2009;16(4):879-95. Review. PubMed PMID: 19387120.

Atamna H. Heme, iron, and the mitochondrial decay of ageing. Ageing Res Rev 3:303–318, 2004.

Baker RD, Greer FR; Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics. 2010 Nov;126(5):1040-50. Epub 2010 Oct 5. PubMed PMID: 20923825.

Beard, J.L. and Connor, J.R. (2003) Iron status and neural functioning. Annu. Rev. Nutr. 23, 41–58

Bishop GM, Robinson SR, Liu Q, Perry G, Atwood CS, Smith MA. Iron: a pathological mediator of Alzheimer disease? Dev Neurosci 24: 184–187, 2002.

Bo S, Menato G, Villois P, Gambino R, Cassader M, Cotrino I, Cavallo-Perin P. Iron supplementation and gestational diabetes in midpregnancy. Am J Obstet Gynecol. 2009 Aug;201(2):158.e1-6. Epub 2009 Jun 13. PubMed PMID: 19527900.

Butterfield DA, Lauderback CM. Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med 32:1050–1060, 2002.

Butterfield DA, Kanski J. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Ageing Dev 122:945–962, 2001.

Butterfield DA, Boyd-Kimball D. Amyloid beta-peptide(1–42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain. Brain Pathol 14:426–432, 2004.

Butterfield DA. Proteomics: a new approach to investigate oxidativestress in Alzheimer’s disease brain. Brain Res 1000:1–7, 2004.

Casadesus G, Smith A, Zhu X, Aliev G, Cash AD, Honda K, Petersen RB, Perry G. Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. J Alzheimers Dis 6: 165–169, 2004.

Crichton, R.R., Charloteaux-Wauters, M. (1987). Iron transport and storage. European Journal of Biochemistry 164, 485-506.

Das, N., Levine, R.L., Orr, W.C., Sohal, R.S. (2001). Selectivity of protein oxidative damage during aging in Drosophila melanogaster. Biochem J 360, 209-16.

DeUngria, M., Rao, R., Wobken, J.D., Luciana, M., Nelson, C.A. and Georgieff, M.K. (2000) Perinatal iron deficiency decreases cytochrome c oxidase (CytOx) activity in selected regions of neonatal rat brain. Pediatr. Res. 48, 169–176

Eaton JW, Qian M. Molecular bases of cellular iron toxicity. Free Radic Biol Med 32:833–840, 2002.

Flint, D.H., Tuminello, J.F., Emptage, M.H. (1993). The inactivation of Fe-S cluster containing hydro-lyases by superoxide. Journal of Biological Chemistry 268, 22369-22376.

Gropper S.S., Smith, Groff Advanced Nutrition and Human Metabolism (5th Edition)

Halliwell, B., Gutteridge, J.M. (1990). Role of free radicals and catalytic metal ions in human disease: an overview. Methods in Enzymology 186, 1-85.

Halliwell, B., Gutteridge, J.M. (1999). Free Radicals in Biology and Medicine, third edition. Oxford University Press, UK.

Heli H, Mirtorabi S, Karimian K. Advances in iron chelation: an update. Expert Opin Ther Pat. 2011 Jun;21(6):819-56. Epub 2011 Mar 30. Review. PubMed PMID: 21449664.

Hisano M, Suzuki R, Sago H, Murashima A, Yamaguchi K. Vitamin B6 deficiency and anemia in pregnancy. Eur J Clin Nutr. 2010 Feb;64(2):221-3. Epub 2009 Nov 18. PubMed PMID: 19920848.

Honda K, Casadesus G, Petersen RB, Perry G, Smith MA. Oxidative stress and redox-active iron in Alzheimer’s disease. Ann N Y Acad Sci 1012:179–182, 2004. J

ehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 2004;27:2422e8.

Liu Q, Sun L, Tan Y, Wang G, Lin X, Cai L. Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications. Curr Med Chem 2009;16:113e29.

Lozoff B, Beard J, Connor J, Barbara F, Georgieff M, Schallert T. Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutr Rev 2006;64:S34–43.

Massie HR, Aiello VR, Williams TR. Inhibition of iron absorption prolongs the life span of Drosophila. Mech Ageing Dev 67:227–237, 1993.

McEchron MD, Cheng AY, Liu H, Connor JR, Gilmartin MR. Perinatal nutritional iron deficiency permanently impairs hippocampus- dependent trace fear conditioning in rats. Nutr Neurosci 2005;8:195–206.

Miwa CP, de Lima MN, Scalco F, Vedana G, Mattos R, Fernandez LL, Hilbig A, Schröder N, Vianna MR. Neonatal iron treatment increases apoptotic markers in hippocampal and cortical areas of adult rats. Neurotox Res. 2011 May;19(4):527-35. Epub 2010 Apr 6. PubMed PMID: 20369315.

Mursu J, Robien K, Harnack LJ, Park K, Jacobs DR Jr. Dietary supplements and mortality rate in older women: the Iowa Women's Health Study. Arch Intern Med. 2011 Oct 10;171(18):1625-33. PubMed PMID: 21987192.

Ong WY, Halliwell B. Iron, atherosclerosis, and neurodegeneration: a key role for cholesterol in promoting iron-dependent oxidative damage? Ann N Y Acad Sci 1012:51–64, 2004.

Perry G, Sayre LM, Atwood CS, Castellani RJ, Cash AD, Rottkamp CA, Smith MA. The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. CNS Drugs 16: 339–352, 2002.

Perry G, Taddeo MA, Petersen RB, Castellani RJ, Harris PL, Siedlak SL, Cash AD, Liu Q, Nunomura A, Atwood CS, Smith MA. Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease. Biometals 16:77–81, 2003.

Poon HF, Calabrese V, Scapagnini G, Butterfield DA. Free radicals and brain aging. Clin Geriatr Med 20:329–359, 2004.

Poon HF, Calabrese V, Scapagnini G, Butterfield DA. Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J Gerontol A Biol Sci Med Sci 59:478–493, 2004.

AAP Section on Breastfeeding, Schanler RJ; Executive Commitee, Feldman-Winter L, Landers S, Noble L, Szucs KA, Viehmann L. Concerns with early universal iron supplementation of breastfeeding infants. Pediatrics. 2011 Apr;127(4):e1097; author reply e1101-4. PubMed PMID: 21460097. S

chipper HM. Brain iron deposition and the free radical-mitochondrial theory of ageing. Ageing Res Rev 3:265–301, 2004.

Siddappa, A.J., Rao, R., Long, J.D., Widness, J.A. and Georgieff, M.K. (2007) The assessment of newborn iron stores at birth: a review of the literature and standards for ferritin concentrations. Neonatology 92, 73–82

Siddappa AM, Georgieff MK, Wewerka S, Worwa C, Nelson CA, Deregnier RA. Iron deficiency alters auditory recognition memory in newborn infants of diabetic mothers. Pediatr Res 2004;55:1034–41.

Sohal RS, Farmer KJ, Allen RG, Ragland SS. Effects of diethyldithiocarbamate on life span, metabolic rate, superoxide dismutase, catalase, inorganic peroxides and glutathione in the adult male housefly, Musca domestica. Mech Ageing Dev 24:175–183, 1984.

Stankiewicz JM, Brass SD. Role of iron in neurotoxicity: a cause for concern in the elderly? Curr Opin Clin Nutr Metab Care. 2009 Jan;12(1):22-9. Review. PubMed PMID: 19057183. S

ullivan JL. Iron and the sex difference in heart disease risk. Lancet 1: 1293–1294, 1981.

Sullivan JL. Are menstruating women protected from heart disease because of, or in spite of, estrogen? Relevance to the iron hypothesis. Am Heart J 145:190–194, 2003.

Swaminathan S, Fonseca VA, AlamMG, Shah SV. The role of iron in diabetes and its complications. Diabetes Care 2007;30:1926e33.

Rao R, Tkac I, Schmidt AT, Georgieff MK. Fetal and neonatal iron deficiency causes volume loss and alters the neurochemical profile of the adult rat hippocampus. Nutr Neurosci. 2011 Mar;14(2):59-65. PubMed PMID: 21605501; PubMed Central PMCID: PMC3170050.

Sies, H. (1997). Oxidative Stress: Oxidants and antioxidants. Experimental Physiology 82, 291-295.

Stoltzfus, R.J. (2001) Defining iron-deficiency anemia in public health terms: a time for reflection. J. Nutr. 131, 565S–567S

Weinberg ED, Iron loading and disease surveillance, Emerging Infectious Diseases 5: May-June, 1999.

Weintraug LR, Current uses of phlebotomy therapy, Hospital Practice, June 15, 1987; Ulvik RJ, Bloodletting as medical therapy for 2500 years, Tidsskr Nor Laegeforen 119: 2487-89, 1999.

World Health Organization (1998) Micronutrient deficiencies, http://www.who.int/nutrition/topics/ida/en/index.html

Yan, L.J., Levine, R.L., Sohal, R.S. (1997). Oxidative damage during aging targets mitochondrial aconitase. Proceedings of the National Academy of Sciences of the United States of America 94, 11168-11172.

Youdim, M.B.H., Sills, M.A., Heydorn, W.E., Creed, G.J. and Jacobowitz, D.M. (1986) Iron deficiency alters discrete proteins in rat caudate nucleus and nucleus accumbens. J. Neurochem. 47, 794–799

Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Iron,brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5: 863–873, 2004.

Niet geciteerd

Polla AS, Polla LL, Polla BS. Iron as the malignant spirit in successful ageing. Ageing Res Rev 2:25–37, 2003.

Ramakrishna G, Rooke TW, Cooper LT. Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light [see comment]. Vasc Med 8:203–210, 2003.

Schipper HM. Brain iron deposition and the free radical-mitochondrial theory of ageing. Ageing Res Rev 3:265–301, 2004.

Connor, J.R. and Menzies, S.L. (1996) Relationship of iron to oligodendrocytes and myelination. Glia 17, 83–93

Beard, J.L., Wiesinger, J.A. and Connor, J.R. (2003) Pre- and postweaning iron deficiency alters myelination in Sprague–Dawley rats. Dev. Neurosci. 25, 308–315